Literature DB >> 9404940

Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients.

D Curti1, F Rognoni, L Gasparini, A Cattaneo, M Paolillo, M Racchi, L Zani, A Bianchetti, M Trabucchi, S Bergamaschi, S Govoni.   

Abstract

Fibroblasts from Alzheimer's disease (AD) patients displayed decreased cytochrome c oxidase (complex IV) activity (P < 0.05). The basal oxygen consumption rate (QO2) and the response to an uncoupler of oxidative phosphorylation did not differ between AD and control fibroblasts. The QO2 of AD fibroblasts was more susceptible (P < 0.05) to inhibition by azide in the range 0.5-5 mM. The basal intracellular pH (pHi) in AD fibroblasts was significantly more acidic than in control ones. The results support the hypothesis that subtle dysfunctions of oxidative energy-producing processes are present in fibroblasts from sporadic AD patients. The alterations observed scantly influence the fibroblasts functioning even in stressful conditions; however in tissues, such as the brain, that rely heavily on oxidative metabolism for their function, similar alterations may trigger molecular mechanisms leading to cell damage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9404940     DOI: 10.1016/s0304-3940(97)00741-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  32 in total

Review 1.  Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.

Authors:  J Eva Selfridge; Lezi E; Jianghua Lu; Russell H Swerdlow
Journal:  Neurobiol Dis       Date:  2012-01-10       Impact factor: 5.996

2.  PET sheds light on Alzheimer's disease genetic risk.

Authors:  Russell H Swerdlow
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-19       Impact factor: 11.205

Review 3.  Estrogen: a master regulator of bioenergetic systems in the brain and body.

Authors:  Jamaica R Rettberg; Jia Yao; Roberta Diaz Brinton
Journal:  Front Neuroendocrinol       Date:  2013-08-29       Impact factor: 8.606

Review 4.  Alzheimer's disease pathologic cascades: who comes first, what drives what.

Authors:  Russell H Swerdlow
Journal:  Neurotox Res       Date:  2011-09-13       Impact factor: 3.911

Review 5.  Brain aging, Alzheimer's disease, and mitochondria.

Authors:  Russell H Swerdlow
Journal:  Biochim Biophys Acta       Date:  2011-09-02

Review 6.  Mitochondria in neurodegeneration.

Authors:  E Lezi; Russell H Swerdlow
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 7.  Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.

Authors:  Russell H Swerdlow
Journal:  Antioxid Redox Signal       Date:  2011-09-15       Impact factor: 8.401

Review 8.  Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention.

Authors:  Diana F Silva; J Eva Selfridge; Jianghua Lu; Lezi E; Sandra M Cardoso; Russell H Swerdlow
Journal:  Adv Pharmacol       Date:  2012

9.  Sporadic Alzheimer disease fibroblasts display an oxidative stress phenotype.

Authors:  Mahesh Ramamoorthy; Peter Sykora; Morten Scheibye-Knudsen; Christopher Dunn; Cindy Kasmer; Yongqing Zhang; Kevin G Becker; Deborah L Croteau; Vilhelm A Bohr
Journal:  Free Radic Biol Med       Date:  2012-08-03       Impact factor: 7.376

Review 10.  Mitochondrial DNA oxidative damage and repair in aging and Alzheimer's disease.

Authors:  Renato X Santos; Sónia C Correia; Xiongwei Zhu; Mark A Smith; Paula I Moreira; Rudy J Castellani; Akihiko Nunomura; George Perry
Journal:  Antioxid Redox Signal       Date:  2012-12-07       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.